12 Episodes

  1. S2 Episode 6: What's New in the Field of Neoadjuvant Therapy and Renal Cell Carcinoma?

    Published: 9/7/2023
  2. S2 Episode 5: The Epidemiology of Renal Cell Carcinoma: Risk Factors, Cystic Disease, the Microbiome, and the Mycobiome

    Published: 8/3/2023
  3. S2 Episode 4: What Can Patient-centered Quality-of-Life Research in Bladder Cancer Teach Us About Kidney Cancer?

    Published: 7/5/2023
  4. S2 Episode 3: Renal Medullary Carcinoma: The Importance of Early and Accurate Screening, Diagnosis, and Treatment

    Published: 6/6/2023
  5. S2 Episode 2: How Single-Cell Sequencing Can Help in Renal Cell Carcinoma

    Published: 5/3/2023
  6. S2 Episode 1: Tissue Biomarkers in Renal Cell Carcinoma: Are We Ready for Prime Time?

    Published: 5/3/2023
  7. S1 Episode 6: Second-Line Treatment of Renal Cell Carcinoma

    Published: 1/5/2023
  8. S1 Episode 5: Biomarkers and Renal Cell Carcinoma

    Published: 12/8/2022
  9. S1 Episode 4: How Does the Gut Microbiome Impact Response to Cancer Therapy?

    Published: 11/2/2022
  10. S1 Episode 3: Non–Clear Cell Renal Cell Carcinoma: A Conversation About Subtypes, Clinical Trials, Treatment Options, and Outcomes

    Published: 10/4/2022
  11. S1 Episode 2: Adjuvant Treatment With Immunotherapy

    Published: 9/1/2022
  12. S1 Episode 1: Frontline Treatment of Renal Cell Carcinoma

    Published: 9/1/2022

1 / 1

Listen to Medscape InDiscussion: Renal Cell Carcinoma, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984237). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.